WELLS DAVID B 4

What Happened
David B. Wells, a director of Hims & Hers Health, Inc. (HIMS), had Restricted Stock Units (RSUs) convert into a total of 4,613 shares of Class A common stock: 3,656 shares on June 11, 2026 and 957 shares on June 15, 2026. The Form 4 shows the derivative conversion entries at $0.00 (no cash paid) — the filing treats the conversion of RSUs into shares as an exercise/conversion event (transaction code M).

Key Details

• Transaction dates: June 11, 2026 (3,656 shares) and June 15, 2026 (957 shares).
• Price / value: conversion shown at $0.00 (no cash paid). One grant of 957 RSUs was issued in lieu of $22,000 in director fees, calculated using a $22.98 grant price.
• Total shares received: 4,613 shares.
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes: RSUs represent a contingent right to receive one share per RSU and vest on the earlier of the 2026 annual meeting or June 15, 2026; the 957-RSU grant was issued under the director compensation policy in lieu of Q1 2026 cash fees.
• Filing timeliness: Form filed June 15, 2026; filing appears timely relative to the reported transaction dates.

Context
This was not an open-market purchase or sale but the vesting/conversion of compensation RSUs into shares (a common, non-cash event for directors). Such conversions reflect compensation vesting rather than a director buying or selling based on market views.